CCitizens JMP MMicrosoft · MSFT

Citizens Reiterates Market Outperform on Microsoft, $550 Price Target

Jun 4, 2026· Analyst: Patrick Walravens· 1 min read· Reproduced verbatim
Rating
Buy
Price target
$550
Previous
Implied upside
+29%

Citizens analyst Patrick Walravens reiterated a Market Outperform rating and $550.00 price target on Microsoft (NASDAQ: MSFT).

“We maintain our Market Outperform rating and $550 price target on Microsoft after attending Microsoft Build on June 2 at Fort Mason, after speaking to 10 customers regarding their spending on Microsoft, and after the stock has fallen 10% YTD versus an increase of 10% for the S&P 500 and an increase of 10% for the Russell 3000.

Some of our key takeaways include: 1) our spending checks were overwhelmingly positive, with 90% of customers we spoke to saying their spend on Microsoft would be up over the next 12-18 months, with the primary theme being increased spend on Azure; and 2) at the keynote, CEO Satya Nadella outlined Microsoft’s evolution to a platform optimized for Agentic AI.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.